About QED Therapeutics & BridgeBio Pharma

QED Therapeutics, an affiliate of BridgeBio Pharma, focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature, which causes potentially debilitating medical complications. With our experimental therapeutic candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families.

Our Business Is Inspired By Our Values

• PUT PATIENTS FIRST
• LET SCIENCE SPEAK
• EVERY MINUTE COUNTS
• THINK INDEPENDENTLY
• BE RADICALLY TRANSPARENT
  
  

FGFR=fibroblast growth factor receptor.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, Raleigh, and with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zug, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at https://www.qedtx.com/ | https://bridgebio.com

Who You Are

The Sr. Medical Director, Medical Affairs will play an essential role in the planning, implementation, and daily operation of drug development program(s). This role is ultimately responsible for supporting the launch of infigratinib for achondroplasia. The Sr. Medical Director will collaborate with key internal and external stakeholders to support the achondroplasia program, contributing scientific knowledge and expertise. Responsible for providing medical support to QED pipeline development, clinical strategy, and post-marketing commitments while supporting Medical Affairs strategy related to Investigator Sponsored Trials.

Responsibilities

• Develop medical content and lead the organization of advisory boards and symposia in support of pipeline programs
• Responsible for engagement with investigative sites, clinical consultants, Key Opinion Leaders (KOLs), and the research community to support company initiatives
• Responsible for developing a training curriculum for new hires
• Medical reviewer and approver for Medical, Commercial, and Advocacy content
• Co-develop Field Medical strategy with the Senior Field Medical/MSL Team lead
• Contribute to and collaborate with clinical development on ongoing and planned clinical trials (phases 2-4)
• Collaborate with clinical development and other cross-functional teams to establish a scientific data disclosure strategy to support registration and launch activities
• Represent QED at scientific, clinical, and business development meetings
• Assist in critically evaluating study results with study investigators
• Work with Scientific Communications to prepare publications and presentations for external meetings
• Function as the medical representative on cross-functional and project team meetings
  
  

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed
  
  

Education, Experience & Skills Requirements

• MD, PharmD, or equivalent
• 7 (or more) years of experience in drug development, either within the industry or as a clinical investigator/physician-scientist in academia, or equivalent experience
• Experience in rare disease fields and/and pediatric endocrinology is a plus
• Strong interpersonal and leadership skills
• Skilled in clinical research and an understanding of the process of pharmaceutical product development and approval
• Experience in product launch development and execution is highly desirable
• Experience in strategy and execution preferred
• Knowledge of regulations impacting Medical Affairs and field activities in the pharmaceutical industry is critical
• Demonstrated ability to organize, prioritize, and work effectively with minimal supervision in a constantly changing environment
• Ability to work independently in a fast-paced environment
• Excellent written and verbal communication skills
• May travel up to 40% domestically and internationally for scientific meetings, advisory boards, etc; evening and weekend work will be involved with some variation based upon the demands of the business imperatives
  
  

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion
  
  

At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states.

Salary

$265,000—$345,000 USD